Search

Obtenga información sobre cómo la nueva investigación y los ensayos clínicos en el Memorial Sloan Kettering Cancer Center (MSK) han ayudado a Giancarlo Oviedo-Mori, de 32 años, a sobrevivir, y prosperar, con cáncer pulmonar avanzado durante 15 años.

… Monday, March 10, 2025 Una noche calurosa y húmeda de 2010, Giancarlo Oviedo-Mori y sus padres recibieron la sorpresa más impactante de sus vidas mientras estaban sentados en un hospital del Bronx. Se enteraron de que Giancarlo padecía un  cáncer pulmonar avanzado de células no pequeñas . Tenía tan solo

What proportion of cancer patients are eligible to benefit from precision oncology? There is an ongoing debate on this issue, partly due to a lack of consensus on which gene mutations are clinically actionable.

… Wednesday, October 18, 2023 What proportion of cancer patients are eligible to benefit from precision oncology? There is an ongoing debate on this issue, partly due to a lack of consensus on which gene mutations are clinically actionable. To answer the question, researchers at Memorial Sloan Kettering

Experts at Memorial Sloan Kettering Cancer Center reviewed the research and found that whole food plant based diets are better than ketogenic diets at reducing cancer risk and helping people after cancer treatment live healthier lives.

… Monday, July 25, 2022 People have sought answers about the relationship between nutrition and health throughout history. In the past few decades, scientific research has uncovered important insights about our diets and cancer, including how food can affect our risk of developing the disease, the treatment

Called NEXT, the factor plays an important role in handing over RNA to the exosome for destruction.

… Thursday, June 9, 2022 In biology, getting rid of stuff can be just as important as making it. A buildup of cells, proteins, or other molecules that are no longer needed can cause problems, so living things have evolved several ways to clean house. A prime example is the RNA exosome. RNA molecules perform

A blood condition related to aging can lead to misinterpreting tumor data.

… Tuesday, June 5, 2018 Summary MSK researchers have found that clonal hematopoiesis (CH) can be misinterpreted as tumor mutations in sequencing tests. CH is a blood condition related to aging that can cause mutations in the blood. Misreading such results could affect treatment decisions. MSK-IMPACT TM

Learn how MSK researchers are investigating the use of nanoparticles to carry drugs across the blood-brain barrier.

… Thursday, March 2, 2023 The blood-brain barrier prevents most drugs from reaching brain tumors. A new method using nanoparticles transported drugs across this barrier in mice. The nanoparticles target a protein on tumor blood vessel cells called P-selectin. The nanoparticles improved the treatment in

Scientists and scholars received degrees and awards at MSK's 40th annual ceremony, held on May 29.

… Friday, May 31, 2019 The GSK class of 2019 The newly minted graduates look on during the ceremony. Craig Thompson, President and CEO of MSK Craig Thompson, President and CEO of MSK, applauds the bright young minds at the 2019 Convocation and Commencement of the Gerstner Sloan Kettering Graduate School

Learn how the Pediatric Translational Medicine Program at Memorial Sloan Kettering is bringing together experts to make new discoveries about pediatric cancer.

… Wednesday, March 6, 2019 Summary A new program at MSK seeks to further harness the power of collaboration to give children innovative treatments, which will in turn help other kids down the line. At MSK Kids, our team of experts puts caring for children and their families in the center of all we do.

The in-person event featured scientific talks from leading women in science, including winners of this year’s Kravis WISE fellowships.

… Thursday, April 14, 2022 Three women standing next to each other in a lobby Marie-Josée Kravis (middle) with 2022 Kravis WiSE fellowship winners Xiuzhen Chen (left) and Brianna Naizir (right) A female scientist speaking at a podium Erika Pearce, PhD, Bloomberg Distinguished Professor at the Johns Hopkins

The incidence of mouth and throat cancer is on the rise due to oral transmission of the human papilloma virus, but the "silver lining" of this phenomenon is doctors at Memorial Sloan Kettering have significantly reduced the intensity of treatment while achieving excellent outcomes for these patients.

… Wednesday, February 15, 2017 The incidence of mouth and throat cancer is on the rise due to transmission of the human papilloma virus (HPV), but the “silver lining” of this phenomenon is doctors at Memorial Sloan Kettering (MSK) can significantly reduce the intensity of treatment and improve quality